GCA Altium advises LDC on its minority investment in ChargePoint Technology Holdings
ChargePoint, which is headquartered in Liverpool, manufactures and supplies its products to the largest global pharmaceutical, bio-pharmaceutical and chemicals companies. Operating across Europe, Asia and North America, its patented technology is used in the development and production of medicines and vaccines by the top 50 Global Pharmaceutical manufacturers, facilitating the safe transfer of highly potent and sterile powders. The business employs over 60 people across the world.
Following LDC’s investment, the business plans to capitalise on the strong and increasing demand for its solutions internationally, in particular North America, whilst accelerating sales of its innovative AseptiSafe® Bio product and investing in the development of new products, particularly in the aftercare market. The investment from LDC will also enable management to embark on a targeted acquisition strategy to help it expand into adjacent sectors requiring containment and sterile transfer solutions.
Chris Eccles, Managing Director at ChargePoint, said: “Over the past 12 months we have continued to invest in both the infrastructure of our business and our product portfolio. We have created a strong platform for future growth and bringing LDC on board as an investment partner is a clear statement of intent regarding our future ambitions. With the team’s track record in the sector and its in-depth experience of delivering international growth, we’re confident we have the right people in place to help us take our market-leading technology even further afield.”
The transaction was led by Ged Gould and Chris Wright at LDC in Manchester. Both will join the board as Non-Executive Directors.
This transaction adds to GCA Altium’s extensive track record in the Industrials sector, having completed 15 transactions in this industry in the last twelve months.
Ged Gould, Director of LDC and Co-Head of the Manchester Office, said: “GCA Altium continues to demonstrate its expertise within the Industrials space and in particular its knowledge of flow control products. Following our successful investment in oil and gas valve manufacturer Bifold, which GCA Altium sold to Rotork for £125 million, they were the obvious choice to provide us with buyside advice on ChargePoint Technology and guided us through a competitive auction process.”